Company Profiles

driven by the PitchBook Platform

MedWell Laboratories

2009 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of non-steroidal anti-inflammatory drugs. The company develops non-steroidal anti-inflammatory drugs for treatment of mild to moderate chronic inflammatory disorders. It develops drug which are effective and safe due to the mechanism of action as cyclooxygenase 2 (COX-2) and 5-Lipoxygenase (5-LOX) enzymes dual inhibition.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
Nazareth Industrial Area
P.O. Box 2252
Nazareth 16000
Israel

+972 (0)4 609 8620
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore MedWell Laboratories’s full profile, request a free trial.

MedWell Laboratories Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding request access »

MedWell Laboratories Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Next Generation Technology Venture Capital Minority 000 0000 000000 0

MedWell Laboratories Executive Team (2)

Name Title Board
Seat
Contact
Info
Michal Olshansky Chief Executive Officer
Taher Nassar Ph.D Co-Founder, Inventor, Board Member & Chief Scientist

MedWell Laboratories Board Members (3)

Name Representing Role Since Contact
Info
Nasri Said MedWell Laboratories Chairman 000 0000
Oren Fuerst Ph.D Self Director 000 0000
Sheila Oren MD Self Board Member 000 0000